EDNRB and ovarian carcinoma: Buchanovich et al. demonstrated the correlation between ETBR expression and poor OS in ovarian cancer, but also showed a correlation with tumor infiltrating lymphocyte (TIL) deficiency, which was reversed by ETBR blockade [85], which improved improving survival in mice.